NATALIE LENNON: Open Payments
NPI 1568176089 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,053 in 93 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $1,506 · 2025 $2,053
Food & beverage: $1,893Education: $160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $337 |
| Incyte Corporation | 19 | $326 |
| Arcutis Biotherapeutics, Inc. | 11 | $298 |
| Janssen Biotech, Inc. | 10 | $242 |
| Amgen Inc. | 10 | $239 |
| PFIZER INC. | 5 | $206 |
| Galderma Laboratories, L.P. | 10 | $165 |
| Lilly USA, LLC | 5 | $102 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $67 |
| LEO Pharma Inc. | 1 | $24 |
Products named: OPZELURA, Zoryve, TREMFYA, RINVOQ, NEMLUVIO, LITFULO, Otezla, TALTZ.
Industry payments across CA — which companies pay providers there.
